Article
Washington-Although urologists were victorious in a recent courtdecision excluding lithotripsy from the Stark II rule, the U.S. Departmentof Health and Human Services said it will appeal the ruling.
Study shows value of precision-based approaches in prostate cancer
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Patient selection for cytoreductive nephrectomy in 2025
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy
Urologic surgeons successfully complete world’s first bladder transplant